鲸鱼电竞直播app网址

April 28th, 2022 · Common Contracts · 1000 similar

Sunshine Biopharma, Inc – SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of April 25, 2022, between Sunshine Biopharma, Inc., a Colorado corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

April 28th, 2022 · Common Contracts · 1000 similar

Sunshine Biopharma, Inc – REGISTRATION RIGHTS AGREEMENT

This Registration Rights Agreement (this “Agreement”) is made and entered into as of April 25, 2022, between Sunshine Biopharma, Inc., a Colorado corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

December 30th, 2014 · Common Contracts · 1000 similar

Oncothyreon Inc. – FORM OF SENIOR INDENTURE BETWEEN ONCOTHYREON INC. AND AS TRUSTEE Dated as of

WHEREAS, the Company has duly authorized the issuance, sale, execution and delivery, from time to time, of its unsecured evidences of indebtedness (hereinafter referred to as the “Securities”), without limit as to principal amount, issuable in one or more series, the amount and terms of each such series to be determined as hereinafter provided; and, to provide the terms and conditions upon which the Securities are to be issued, authenticated and delivered, the Company has duly authorized the execution of this Indenture; and

March 25th, 2020 · Common Contracts · 1000 similar

Aikido Pharma Inc. – RIGHTS AGREEMENT

This RIGHTS AGREEMENT, dated as of March 23, 2020 (this “Agreement”), by and between AIkido Pharma Inc., a Delaware corporation (the “Company”), and VStock Transfer, LLC, as rights agent (the “Rights Agent”).

June 22nd, 2020 · Common Contracts · 1000 similar

Precigen, Inc. – INDENTURE DATED AS OF , 20 BETWEEN PRECIGEN, INC. as Issuer, AND as Trustee Providing for Issuance of Debt Securities in Series

THIS INDENTURE, dated as of , 20 , between PRECIGEN, INC., a corporation duly organized and existing under the laws of the State of Virginia (herein called the “Company”), and , as trustee (herein called the “Trustee”).

November 9th, 2015 · Common Contracts · 1000 similar

Albany Molecular Research Inc – SECOND AMENDED AND RESTATED CREDIT AGREEMENT dated as of August 19, 2015 among ALBANY MOLECULAR RESEARCH, INC., as Borrower, THE LENDERS AND L/C ISSUERS FROM TIME TO TIME PARTY HERETO, BARCLAYS BANK PLC, as Administrative Agent, Collateral Agent, L/C...

This Second Amended and Restated Credit Agreement (as may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), is entered into as of August 19, 2015, by and among Albany Molecular Research, Inc., a Delaware corporation (the “Borrower”), the Lenders and L/C Issuers (each as hereinafter defined) from time to time party hereto and Barclays Bank PLC, as the Administrative Agent, the Collateral Agent, the Swing Line Lender (each as hereinafter defined) and a L/C Issuer.

May 25th, 2011 · Common Contracts · 990 similar

Bioheart, Inc. – SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 16, 2011, by and between BIOHEART, INC., a FLORIDA corporation, with headquarters located at 13794 NW 4TH STREET, SUITE 212, SUNRISE, FL33325 (the “Company”), and MAGNA GROUP, LLC, a Texas corporation, with its address at 1120 Old Country Road, Suite 303, Plainview, NY 11803 (the “Buyer”).

March 16th, 2010 · Common Contracts · 990 similar

Kendle International Inc – CREDIT AGREEMENT dated as of March 15, 2010 among KENDLE INTERNATIONAL INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent J.P. MORGAN SECURITIES INC. as Sole Bookrunner and Sole Lead Arranger

CREDIT AGREEMENT (this “Agreement”) dated as of March 15, 2010 among KENDLE INTERNATIONAL INC., the LENDERS from time to time party hereto and JPMORGAN CHASE BANK, N.A., as Administrative Agent.

April 9th, 2015 · Common Contracts · 914 similar

Dyax Corp – DYAX CORP. (a Delaware corporation) 7,400,000 Shares of Common Stock UNDERWRITING AGREEMENT

October 18th, 2021 · Common Contracts · 846 similar

PPD, Inc. – AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT

THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of the 6th day of October, 2021, by and among Science 37 Holdings, Inc., a Delaware corporation (f/k/a LifeSci Acquisition II Corp.) (the “Company”), the equityholders designated as Sponsor Equityholders on Schedule A hereto (collectively, the “Sponsor Equityholders”) and the equityholders designated as Legacy Science 37 Equityholders on Schedule B hereto (collectively, the “Legacy Science 37 Equityholders” and, together with the Sponsor Equityholders and any person or entity who hereafter becomes a party to this Agreement pursuant to Section 6.2 of this Agreement, each an “Investor” and collectively, the “Investors”).

July 13th, 2020 · Common Contracts · 791 similar

Nanoviricides, Inc. – UNDERWRITING AGREEMENT between NANOVIRICIDES, INC. and KINGSWOOD CAPITAL MARKETS, A DIVISION OF BENCHMARK INVESTMENTS INC., as Representative of the Several Underwriters NANOVIRICIDES, INC. UNDERWRITING AGREEMENT

Kingswood Capital Markets, a division of Benchmark Investments, Inc. As Representative of the several Underwriters named on Schedule 1 attached hereto 71 Battery Place, Suite 625

February 23rd, 2011 · Common Contracts · 786 similar

Exact Sciences Corp – RIGHTS AGREEMENT Dated as of February 22, 2011

THIS RIGHTS AGREEMENT, dated as of February 22, 2011 (this “Agreement”), is made and entered into by and between Exact Sciences Corporation, a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, as Rights Agent (the “Rights Agent”).

December 31st, 2020 · Common Contracts · 686 similar

iSpecimen Inc. – ISPECIMEN INC. INDEMNIFICATION AGREEMENT

This Indemnification Agreement (this “Agreement”) is made and entered into on , by and between iSpecimen Inc., a Delaware corporation (the “Company”), and (“Indemnitee”).

November 13th, 2007 · Common Contracts · 681 similar

Crucell Nv – and OWNERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY RECEIPTS Deposit Agreement Dated as of October 26, 2000

February 16th, 2021 · Common Contracts · 670 similar

Medpace Holdings, Inc. – INDEMNIFICATION AGREEMENT

This Indemnification Agreement (“Agreement”) is made effective as of [ ● ], 20[ ● ] by and between Medpace Holdings, Inc., a Delaware corporation (the “Company”), and ___________ (“Indemnitee”).

August 9th, 2018 · Common Contracts · 627 similar

PRA Health Sciences, Inc. – 6,500,000 Shares of Common Stock PRA Health Sciences, Inc. UNDERWRITING AGREEMENT

July 15th, 2021 · Common Contracts · 599 similar

Absci Corp – ABSCI CORPORATION [●] Shares of Common Stock Underwriting Agreement

Absci Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [●] shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.

May 9th, 2013 · Common Contracts · 532 similar

Senesco Technologies Inc – SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of May 9, 2013, between Senesco Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

January 31st, 2018 · Common Contracts · 467 similar

Cascadian Therapeutics, Inc. – AGREEMENT AND PLAN OF MERGER

This Agreement and Plan of Merger (this “Agreement”), dated as of January 30, 2018, is among Seattle Genetics, Inc., a Delaware corporation (“Parent”), Valley Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”), and Cascadian Therapeutics, Inc., a Delaware corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the respective meanings set forth in Annex A and Exhibit A attached hereto, as applicable.

May 25th, 2001 · Common Contracts · 449 similar

Cytomedix Inc – EXHIBIT 10.37 REGISTRATION RIGHTS AGREEMENT (Series 2001 12% Convertible Promissory Notes) REGISTRATION RIGHTS AGREEMENT (this "AGREEMENT"), dated as of April 23, 2001, by CYTOMEDIX, INC., a Delaware corporation, with its headquarters located at Three...

August 8th, 2018 · Common Contracts · 426 similar

Syneos Health, Inc. – Syneos Health, Inc. Class A Common Stock Underwriting Agreement

The stockholders named in Schedule II hereto (the “Selling Stockholders”) of Syneos Health, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Morgan Stanley & Co. LLC as set forth in Schedule I hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof, and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis) an aggregate of 6,000,000 shares (the “Shares”) of Class A Common Stock, par value $0.01 (“Stock”) of the Company.

May 8th, 2009 · Common Contracts · 417 similar

Exelixis Inc – EXELIXIS, INC., Issuer AND WELLS FARGO BANK, NATIONAL ASSOCIATION, Trustee INDENTURE Dated as of [•], 200 Subordinated Debt Securities

INDENTURE, dated as of [•], 200 , among Exelixis, Inc., a Delaware corporation (the “Company”), and Wells Fargo Bank, National Association, a national banking association, as trustee (the “Trustee”):

February 15th, 2005 · Common Contracts · 405 similar

Senomyx Inc – SENOMYX, INC. and MELLON INVESTOR SERVICES LLC as Rights Agent RIGHTS AGREEMENT Dated as of February 14, 2005

THIS RIGHTS AGREEMENT (“Agreement”), dated as of February 14, 2005, between SENOMYX, INC., a Delaware corporation (the “Company”), and MELLON INVESTOR SERVICES LLC (“Rights Agent”).

June 24th, 2020 · Common Contracts · 400 similar

Iqvia Holdings Inc. – INDENTURE Dated as of June 24, 2020 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank National Association, as Trustee 2.875% SENIOR NOTES DUE 2028

INDENTURE, dated as of June 24, 2020, among IQVIA Inc., a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank National Association, as Trustee.

August 13th, 2007 · Common Contracts · 400 similar

Pharmacopeia Drug Discovery Inc – INDENTURE BETWEEN PHARMACOPEIA, INC. AND AS TRUSTEE DATED AS OF , 200 SENIOR DEBT SECURITIES

INDENTURE, dated as of , between PHARMACOPEIA, INC., a Delaware corporation (the “Company”), having its principal office at , and , as trustee, (the “Trustee”), the office of the Trustee at which at the date hereof its corporate trust business is principally administered being .

June 8th, 2005 · Common Contracts · 380 similar

Neogenomics Inc – REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of June 6, 2005 by and between NEOGENOMICS, INC., a Nevada corporation (the "Company"), and CORNELL CAPITAL PARTNERS, LP, a Delaware limited partnership (the...

March 2nd, 2022 · Common Contracts · 374 similar

AIkido Pharma Inc. – SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of February 24, 2022, between Aikido Pharma Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

October 26th, 2015 · Common Contracts · 374 similar

Anavex Life Sciences Corp. – REGISTRATION RIGHTS AGREEMENT

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of October 21, 2015, by and between ANAVEX LIFE SCIENCES CORP., a Nevada corporation (the “Company”), and LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company (together with it permitted assigns, the “Buyer”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement by and between the parties hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

July 8th, 2020 · Common Contracts · 370 similar

Tenax Therapeutics, Inc. – SECURITIES PURCHASE AGREEMENT FOR CLASS C AND CLASS D UNITS

This Securities Purchase Agreement for Class C and Class D Units (this “Agreement”) is dated as of July 6, 2020, between Tenax Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

November 16th, 2018 · Common Contracts · 350 similar

Eloxx Pharmaceuticals, Inc. – ELOXX PHARMACEUTICALS, INC. AND [•], AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [•], 20[•] ELOXX PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENT

THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [•], between ELOXX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).

March 23rd, 2021 · Common Contracts · 338 similar

Zymergen Inc. – Contract

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTIONS 5.3 AND 5.4 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.

July 27th, 2021 · Common Contracts · 337 similar

WCG Clinical, Inc. – WCG Clinical, Inc. Common Stock Underwriting Agreement

WCG Clinical, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of the Company’s common stock, par value $0.01 per share (“Stock”). The Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.”

February 8th, 2007 · Common Contracts · 334 similar

Alion Science & Technology Corp – ALION SCIENCE AND TECHNOLOGY CORPORATION 101/4% Senior Notes due 2015 REGISTRATION RIGHTS AGREEMENT

Alion Science and Technology Corporation, a Delaware corporation (the “Issuer”), proposes to issue and sell to Credit Suisse Securities (USA) LLC (the “Purchaser”), upon the terms set forth in a purchase agreement of even date herewith (the “Purchase Agreement”), $250,000,000 aggregate principal amount of its 101/4% Senior Notes due 2015 (the “Initial Securities”), to be unconditionally guaranteed by the Guarantors (as such term is defined in the Purchase Agreement and, together with the Issuer, the “Company”). The Initial Securities will be issued pursuant to an Indenture, dated February 8, 2007 (the “Indenture”), among the Issuer, the Guarantors and Wilmington Trust Company (the “Trustee”). As an inducement to the Purchaser, the Company agrees with the Purchaser, for the benefit of the holders of the Initial Securities (including, without limitation, the Purchaser), the Exchange Securities (as defined below) and the Private Exchange Securities (as defined below) (collectively the “Ho

September 14th, 2018 · Common Contracts · 319 similar

Sunshine Biopharma, Inc – REGISTRATION RIGHTS AGREEMENT

This REGISTRATION RIGHTS AGREEMENT (the “Agreement”), dated as of September 10, 2018 (the “Execution Date”), is entered into by and between Sunshine Biopharma Inc., a Colorado corporation with its principal executive office at 6500 Trans-Canada Highway, 4th Floor, Pointe-Claire, Quebec, Canada H9R 0A5 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with offices at 420 Jericho Turnpike, Jericho, NY 11753 (the “Investor”).

August 3rd, 2020 · Common Contracts · 317 similar

Nanoviricides, Inc. – NANOVIRICIDES, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales Agreement